Clinical Trial

Sonazoid CEUS for Early HCC Surveillance

Name: Sonazoid CEUS for Early HCC Surveillance — clinical trial record (NCT07590284)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study is a multicenter, prospective study. In this study, enrolled subjects are cirrhotic patients of any etiology. The US and Sonazoid CEUS monitoring strategy was performed for cirrhotic patients: US and AFP joint with Sonazoid CEUS every 4 to 6 months, and combined CECT/CEMRI every 12 months.

Trial Details

NCT Number	NCT07590284
Lead Sponsor	Tianjin Third Central Hospital
Conditions	Liver Cirrhosis, Liver Fibrosis
Enrollment	556 participants
Start Date	2026-05-30
Primary Completion	2029-12-30 (estimated)
Study Completion	2029-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-15